The MAQI2 is an ongoing, multicenter, regional, collaborative registry of anticoagulation care, which seeks to improve the safety, quality of care and outcomes of patients requiring anticoagulation.
The MAQI2 is an ongoing, multicenter, regional, collaborative registry of anticoagulation care, which seeks to improve the safety, quality of care and outcomes of patients requiring anticoagulation. Patients who receive anticoagulant therapy in the outpatient setting at five sites in Michigan (UMHS, Henry Ford Medical Center, Beaumont Hospital in Royal Oak, Detroit Medical
Center, and West Michigan Heart) will have their de-identified data collected and put into a data registry at the MAQI2 Coordinating Center located within MCORRP.
Data collected will include patient demographics, time in therapeutic range (TTR), frequency of adverse events including ED visits and inpatient admissions, and descriptors of the anticoagulation system structure and function.
Risk adjustment models will be developed from the initial data collected. Observed and predicted long-term outcomes will be evaluated. Quality improvement initiatives will be developed and deployed through the collaborative. Observed and risk-adjusted outcomes in the pre and post quality improvement intervention periods will be compared. Elements of ACS that correlate with high-quality care and fewer adverse outcomes will be identified and shared with ACS providers state-wide.
The MAQI2 was created through generous ongoing funding from Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN). This funding significantly reduces barriers for Michigan cardiologists and hospitals wishing to participate in - and benefit from - the program.
Please click here to go to the Data Entry application.
Please click here for the Provider Survey.